MedSetGo Closes $2.4M Oversubscribed Seed Round to Transform Healthcare Navigation with AI

Published On: Sep 15, 2025 (UTC)

AI-driven company exceeds funding target by 20% to modernize patient care transitions

SAN FRANCISCO, CA - Sep 15, 2025 (UTC) - MedSetGo, an AI-driven healthcare company modernizing patient care transitions, announced the close of its $2.4 million oversubscribed seed round, exceeding its target by 20%. The round was led by TurboStart with participation from Gold House Ventures, which also invested in MedSetGo’s pre-seed round, as well as a series of high profile angel investors.

The new funding will accelerate product development and hiring, with a focus on expanding its engineering, data science, and commercialization teams. MedSetGo leverages artificial intelligence to reduce clinician burden, improve efficiency, and enhance patient outcomes by streamlining the process of finding and scheduling the right care after discharge.

“The post-acute care ecosystem in the US is broken—held together by fax machines and phone calls. MedSetGo is solving this with deep empathy, strong product thinking, and a real-world understanding of the care journey. Their traction across hospitals, health plans, and service providers gives us confidence that they’re building not just a tool, but critical infrastructure,” said Ganesh Raju, Founder of TurboStart.

The healthcare technology sector continues to see significant investment as companies work to modernize antiquated systems and improve patient care coordination. MedSetGo’s platform addresses a critical gap in healthcare infrastructure by using AI to facilitate smoother transitions between different levels of care.

“Healthcare is long overdue for innovation, and AI gives us the opportunity to redesign how patients move across the system. At MedSetGo, we’re focused on being a true healthcare partner—streamlining the process of finding and scheduling the right care after discharge. TurboStart and Gold House Ventures have been incredible partners on this journey, and we’re deeply grateful to all our investors and advisors who believe in our mission to modernize care transitions,” said Shrey Kapoor, Founder & CEO of MedSetGo.

TurboStart is a global fund that provides seed and pre-Series A funding to early-stage, tech-driven startups, combining the functions of an incubator, accelerator, and venture fund. The firm invests in B2B tech, SaaS, fintech, and consumer tech, with particular interest in startups leveraging AI, blockchain, and other advanced technologies. Gold House Ventures focuses on investing in diverse founders building scalable technology companies.

About MedSetGo

MedSetGo is a San Francisco-based healthcare technology company leveraging artificial intelligence to reduce clinician burden, improve efficiency, and enhance patient outcomes. The company focuses on modernizing patient care transitions by streamlining the process of finding and scheduling appropriate care after discharge. Founded and led by CEO Shrey Kapoor, MedSetGo serves hospitals, health plans, and service providers with its AI-driven platform designed to replace outdated communication methods like fax machines and phone calls with modern, efficient digital solutions. For more information, visit https://medsetgo.ai/.